Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Buy
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Moleculin Biotech, Inc. (MBRX)
Pharmaceutical Preparations
Moleculin Biotech Inc is a clinical-stage pharmaceutical company with a focus on the treatment of highly resistant cancers and viruses through the development of its drug candidates. The company has three core technologies: Annamycin which is a next-generation anthracycline; Immune/Transcription Modulators, of which WP1066 is a member; and Metabolism/Glycosylation Inhibitors, of which WP1122 is a member.
5300 MEMORIAL DRIVE, SUITE 950
HOUSTON, TX
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/02/2016
Market Cap
5,814,673
Shares Outstanding
33,409,999
Weighted SO
33,412,696
Total Employees
N/A
Upcoming Earnings
08/09/2024
Beta
1.8360
Last Div
0.0000
Range
0.338-6.24
Chg
0.0400
Avg Vol
29038
Mkt Cap
5814673
Exch
NASDAQ
Country
US
Phone
713 300 5160
DCF Diff
-7.5898
DCF
11.6298
Div Yield
0.0000
P/S
14.3219
EV Multiple
0.1630
P/FV
0.3261
Div Yield %
0.0000
P/E
-0.2294
PEG
0.0471
Payout
0.0000
Current Ratio
2.3897
Quick Ratio
2.3897
Cash Ratio
1.8874
DSO
8.0911
DIO
0.0000
Op Cycle
8.0911
DPO
7954.1923
CCC
-7946.1012
Gross Margin
0.6798
Op Margin
-68.2956
Pretax Margin
-61.9877
Net Margin
-61.9877
Eff Tax Rate
-0.0407
ROA
-0.9840
ROE
-1.0016
ROCE
-1.3984
NI/EBT
1.0000
EBT/EBIT
0.9076
EBIT/Rev
-68.2956
Debt Ratio
0.0208
D/E
0.0300
LT Debt/Cap
0.0232
Total Debt/Cap
0.0292
Int Coverage
-63.1617
CF/Debt
-48.1654
Equity Multi
1.4445
Rec Turnover
45.1111
Pay Turnover
0.0459
Inv Turnover
0.0000
FA Turnover
0.5833
Asset Turnover
0.0159
OCF/Share
-10.0753
FCF/Share
-10.1233
Cash/Share
4.2642
OCF/Sales
-63.1133
FCF/OCF
1.0048
CF Coverage
-48.1654
ST Coverage
-228.7857
CapEx Coverage
-210.0328
Div&CapEx Cov
-210.0328
P/BV
0.3261
P/B
0.3261
P/S
14.3219
P/E
-0.2294
P/FCF
-0.2258
P/OCF
-0.2253
P/CF
-0.2253
PEG
0.0471
P/S
14.3219
EV Multiple
0.1630
P/FV
0.3261
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
556.01K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
26.63K Shares Bought (45.37 %)
32.06K Shares Sold (54.63%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 406.00K | ▼ 0.00 |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 28.00K | ▲ 35.00K | ▼ 32.00K |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -28.00K | ▲ 371.00K | ▼ -32.00K |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.91 | ▼ 0.00 |
Research And Development Expenses | 2.93M | ▲ 3.20M | ▼ 1.79M | ▲ 3.18M | ▲ 4.18M | ▲ 6.63M | ▼ 4.25M |
General And Administrative Expenses | 1.37M | ▲ 1.56M | ▲ 1.66M | ▲ 1.99M | ▲ 2.84M | ▼ 2.25M | ▲ 2.39M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 1.37M | ▲ 1.56M | ▲ 1.66M | ▲ 1.99M | ▲ 2.84M | ▼ 2.25M | ▲ 2.39M |
Other Expenses | -17.00K | ▲ 10.00K | ▼ -4.00K | ▲ 10.00K | ▲ 32.00K | ▼ -492.00K | ▲ 11.00K |
Operating Expenses | 4.34M | ▲ 4.81M | ▼ 3.50M | ▲ 5.21M | ▲ 7.05M | ▲ 8.88M | ▼ 6.65M |
Cost And Expenses | 4.34M | ▲ 4.81M | ▼ 3.50M | ▲ 5.21M | ▲ 7.05M | ▲ 8.92M | ▼ 6.68M |
Interest Income | 0.00 | 0.00 | ▼ -10.00K | ▲ 70.00K | ▲ 207.00K | ▲ 262.00K | ▼ 241.00K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.14M | ▲ 439.00K | ▼ 0.00 |
Depreciation And Amortization | 41.00K | ▲ 52.00K | ▼ 46.00K | ▼ 34.00K | ▼ -119.00K | ▲ 35.00K | ▼ 32.00K |
Ebitda | -5.87M | ▲ -5.76M | ▲ -4.31M | ▼ -7.47M | ▲ -7.17M | ▼ -8.88M | ▲ -6.65M |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -21.88 | ▲ 0.00 |
Operating Income | -4.34M | ▼ -4.81M | ▲ -3.50M | ▼ -5.21M | ▼ -7.05M | ▼ -8.92M | ▲ -6.68M |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -21.97 | ▲ 0.00 |
Total Other Income Expenses Net | 1.55M | ▼ 1.01M | ▼ 853.00K | ▲ 2.31M | ▼ 278.00K | ▼ -1.35M | ▲ 1.71M |
Income Before Tax | -2.79M | ▼ -3.80M | ▲ -2.64M | ▼ -2.83M | ▼ -6.77M | ▼ -10.27M | ▲ -4.97M |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -25.29 | ▲ 0.00 |
Income Tax Expense | -1.57M | ▲ 229.00K | ▼ -860.00K | ▼ -2.37M | ▲ -1.14M | ▲ 965.00K | ▼ 0.00 |
Net Income | -2.79M | ▼ -3.80M | ▲ -2.64M | ▼ -2.83M | ▼ -5.63M | ▼ -10.27M | ▲ -4.97M |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -25.29 | ▲ 0.00 |
Eps | -0.65 | ▲ -0.56 | ▲ -0.27 | ▲ -0.11 | ▼ -2.95 | ▼ -5.13 | ▲ -2.02 |
Eps Diluted | -0.65 | ▲ -0.56 | ▲ -0.27 | ▲ -0.11 | ▼ -2.95 | ▼ -5.13 | ▲ -2.02 |
Weighted Average Shs Out | 4.32M | ▲ 6.79M | ▲ 9.85M | ▲ 26.88M | ▼ 1.91M | ▲ 2.00M | ▲ 2.47M |
Weighted Average Shs Out Dil | 4.32M | ▲ 6.79M | ▲ 9.85M | ▲ 26.88M | ▼ 1.91M | ▲ 2.00M | ▲ 2.47M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 7.13M | ▲ 10.74M | ▲ 15.17M | ▲ 70.90M | ▼ 43.15M | ▼ 23.55M | ▼ 16.82M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 7.13M | ▲ 10.74M | ▲ 15.17M | ▲ 70.90M | ▼ 43.15M | ▼ 23.55M | ▼ 16.82M |
Net Receivables | 0.00 | ▲ 11.00K | ▼ 1.00K | ▲ 45.00K | ▼ 22.00K | ▲ 99.00K | ▼ 0.00 |
Inventory | 0.00 | ▲ 2.21M | ▼ 1.86M | ▼ 0.00 | ▼ -22.00K | ▲ 0.00 | 0.00 |
Other Current Assets | 840.00K | ▼ 529.00K | ▼ 164.00K | ▲ 1.55M | ▲ 2.45M | ▲ 2.62M | ▼ 2.13M |
Total Current Assets | 7.97M | ▲ 13.48M | ▲ 17.20M | ▲ 72.50M | ▼ 45.60M | ▼ 26.27M | ▼ 18.96M |
Property Plant Equipment Net | 463.00K | ▲ 603.00K | ▲ 685.00K | ▼ 445.00K | ▲ 678.00K | ▲ 796.00K | ▼ 740.00K |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 11.14M | ▼ 0.00 |
Intangible Assets | 11.15M | 11.15M | ▼ 0.00 | ▲ 11.15M | 11.15M | ▼ 11.15K | ▲ 11.15M |
Goodwill And Intangible Assets | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M | 11.15M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.00 | -1.00 |
Total Non Current Assets | 11.61M | ▲ 11.75M | ▲ 11.83M | ▼ 11.59M | ▲ 11.83M | ▲ 11.94M | ▼ 11.89M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | 1.00 |
Total Assets | 19.59M | ▲ 25.24M | ▲ 29.03M | ▲ 84.09M | ▼ 57.42M | ▼ 38.22M | ▼ 30.85M |
Account Payables | 1.25M | ▲ 2.15M | ▼ 1.13M | ▲ 1.36M | ▲ 2.10M | ▲ 2.50M | ▼ 2.10M |
Short Term Debt | 0.00 | ▲ 103.00K | ▲ 118.00K | ▼ 96.00K | ▲ 116.00K | ▼ 100.00K | ▲ 109.00K |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Revenue | 0.00 | ▲ 1.15M | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Current Liabilities | 2.63M | ▼ 164.00K | ▲ 1.67M | ▲ 2.16M | ▲ 2.61M | ▲ 4.22M | ▼ 3.20M |
Total Current Liabilities | 3.88M | ▼ 3.57M | ▼ 2.92M | ▲ 3.62M | ▲ 4.82M | ▲ 6.82M | ▼ 5.41M |
Long Term Debt | 0.00 | ▲ 276.00K | ▼ 159.00K | ▼ 63.00K | ▲ 335.00K | ▲ 474.00K | ▼ 450.00K |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 1.44M | ▲ 5.82M | ▲ 8.19M | ▼ 1.41M | ▼ 77.00K | ▲ 4.86M | ▼ 3.40M |
Total Non Current Liabilities | 1.44M | ▲ 6.09M | ▲ 8.35M | ▼ 1.48M | ▼ 412.00K | ▲ 5.33M | ▼ 3.85M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 379.00K | ▼ 277.00K | ▼ 159.00K | ▲ 451.00K | ▲ 474.00K | ▼ 450.00K |
Total Liabilities | 5.31M | ▲ 9.66M | ▲ 11.27M | ▼ 5.10M | ▲ 5.23M | ▲ 12.14M | ▼ 9.26M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 29.00K | ▲ 46.00K | ▲ 69.00K | ▼ 29.00K | 29.00K | ▲ 33.00K | ▼ 2.00K |
Retained Earnings | -26.36M | ▼ -39.56M | ▼ -56.92M | ▼ -72.81M | ▼ -101.84M | ▼ -131.60M | ▼ -136.57M |
Accumulated Other Comprehensive Income Loss | 35.00K | ▼ 31.00K | ▲ 65.00K | ▼ 41.00K | ▼ 12.00K | ▼ -9.00K | ▼ -18.00K |
Other Total Stockholders Equity | 40.56M | ▲ 55.06M | ▲ 74.54M | ▲ 151.73M | ▲ 153.99M | ▲ 157.65M | ▲ 158.18M |
Total Stockholders Equity | 14.27M | ▲ 15.57M | ▲ 17.76M | ▲ 78.99M | ▼ 52.19M | ▼ 26.07M | ▼ 21.59M |
Total Equity | 14.27M | ▲ 15.57M | ▲ 17.76M | ▲ 78.99M | ▼ 52.19M | ▼ 26.07M | ▼ 21.59M |
Total Liabilities And Stockholders Equity | 19.59M | ▲ 25.24M | ▲ 29.03M | ▲ 84.09M | ▼ 57.42M | ▼ 38.22M | ▼ 30.85M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 19.59M | ▲ 25.24M | ▲ 29.03M | ▲ 84.09M | ▼ 57.42M | ▼ 38.22M | ▼ 30.85M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 0.00 | ▲ 379.00K | ▼ 277.00K | ▼ 159.00K | ▲ 451.00K | ▲ 574.00K | ▼ 559.00K |
Net Debt | -7.13M | ▼ -10.36M | ▼ -14.90M | ▼ -70.74M | ▲ -42.69M | ▲ -22.98M | ▲ -16.27M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2020 | 2021 | 2022 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -3.80M | ▲ -2.64M | ▼ -2.83M | ▲ 0.00 | ▼ -6.77M | ▼ -10.27M | ▲ -4.97M |
Depreciation And Amortization | 52.00K | ▼ 46.00K | ▼ 34.00K | ▼ 0.00 | ▲ 32.00K | ▲ 35.00K | ▼ 32.00K |
Deferred Income Tax | -1.00M | ▲ -851.00K | ▼ -2.30M | ▲ 0.00 | 0.00 | ▼ -59.00K | ▲ 0.00 |
Stock Based Compensation | 382.00K | ▲ 415.00K | ▲ 556.00K | ▼ 0.00 | ▲ 535.00K | ▼ 479.00K | ▲ 493.00K |
Change In Working Capital | -306.00K | ▲ -90.00K | ▲ 283.00K | ▼ 0.00 | ▼ -898.00K | ▲ 3.21M | ▼ -925.00K |
Accounts Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payables | -1.04M | ▲ -214.00K | ▲ -26.00K | ▲ 0.00 | ▼ -1.47M | ▲ 490.00K | ▼ -394.00K |
Other Working Capital | 729.00K | ▼ 124.00K | ▲ 309.00K | ▼ 0.00 | ▲ 575.00K | ▲ 2.72M | ▼ -531.00K |
Other Non Cash Items | -4.00K | ▼ -5.00K | ▼ -6.00K | ▲ 0.00 | ▼ -155.00K | ▲ 1.19M | ▼ -396.00K |
Net Cash Provided By Operating Activities | -4.68M | ▲ -3.12M | ▼ -4.26M | ▲ 0.00 | ▼ -7.26M | ▲ -5.41M | ▼ -6.72M |
Investments In Property Plant And Equipment | -10.00K | ▼ -16.00K | ▼ -19.00K | ▲ 0.00 | ▼ -67.00K | ▼ -81.00K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 1.00K | ▲ 2.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash Used For Investing Activities | -9.00K | ▼ -14.00K | ▼ -19.00K | ▲ 0.00 | ▼ -67.00K | ▼ -81.00K | ▲ 0.00 |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | ▲ 5.48M | ▼ -1.00K | ▲ 0.00 | 0.00 | ▲ 3.96M | ▼ 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 772.03K | ▼ 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | ▲ 1.00K | ▼ 0.00 | ▼ -12.00K | ▲ 4.47K | ▼ 0.00 |
Net Cash Used Provided By Financing Activities | 0.00 | ▲ 5.48M | ▼ -1.00K | ▲ 0.00 | ▼ -12.00K | ▲ 4.47K | ▼ 0.00 |
Effect Of Forex Changes On Cash | 12.00K | ▲ 32.00K | ▼ 2.00K | ▼ 0.00 | ▲ 9.00K | ▼ -6.00K | ▼ -9.00K |
Net Change In Cash | -4.67M | ▲ 2.38M | ▼ -4.28M | ▲ 0.00 | ▼ -7.25M | ▲ -1.03M | ▼ -6.73M |
Cash At End Of Period | 10.74M | ▲ 15.17M | ▲ 70.90M | ▼ 0.00 | ▲ 43.15M | ▼ 23.55M | ▼ 16.82M |
Cash At Beginning Of Period | 15.41M | ▼ 12.80M | ▲ 75.18M | ▼ 0.00 | ▲ 50.39M | ▼ 24.58M | ▼ 23.55M |
Operating Cash Flow | -4.68M | ▲ -3.12M | ▼ -4.26M | ▲ 0.00 | ▼ -7.26M | ▲ -5.41M | ▼ -6.72M |
Capital Expenditure | -10.00K | ▼ -16.00K | ▼ -19.00K | ▲ 0.00 | ▼ -67.00K | ▼ -81.00K | ▲ 0.00 |
Free Cash Flow | -4.69M | ▲ -3.14M | ▼ -4.28M | ▲ 0.00 | ▼ -7.32M | ▲ -5.49M | ▼ -6.72M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)